magnesium(2+)Finding
Magnesium(2+) decreases Insomnia Severity Index (ISI) total score
lowersModerate evidenceFinding
01 · The sentence it was drawn from
“Based on the intention-to-treat GLMM analysis detailed in Table 2, the magnesium bisglycinate group had a statistically significantly greater between-group mean reduction in ISI scores from baseline to Week 4 [−3.9 (95% CI, −5.8 to −2.0)] compared to the placebo group [−2.3 (95% CI, −4.1 to −0.4)] (p = 0.049).”
magnesium(2+)
Insomnia Severity Index (ISI) total score
lowers
- Who
- Adults aged 18 to 65 years in good health reporting poor sleep for more than four weeks (RIS score above 12); intention-to-treat, GLMM-adjusted for baseline ISI, age, sex, BMI and occupation
- Dose studied
- magnesium bisglycinate, two capsules daily 30-60 minutes before bedtime, 250 mg elemental magnesium and 1523 mg glycine per day
Moderate evidencePMID 40918053 · 2025
02 · The study
- Study
- RCT
- Duration
- 4 weeks
Evidence, by strength
- strong
- moderatethis finding
- limited
- very limited
- insufficient
03 · The paper
Nature and science of sleep2025PMID 40918053doi 10.2147/NSS.S524348An author is affiliated with a producer
04 · To cite this finding
This address does not changehttps://catalystproject.ai/e/01M7E57HGYW7XWW76740XMDJ7N